Literature DB >> 1630978

Extended transduodenal sphincteroplasty for bile duct stones associated with a periampullary diverticulum.

M Akoglu1, B Sahin, B R Davidson.   

Abstract

Extended transduodenal sphincteroplasty has been suggested as an alternative to choledochoduodenostomy for the surgical management of bile duct stones associated with a periampullary diverticulum but its value has not previously been investigated. Over a 3 year period, nine patients underwent extended transduodenal sphincteroplasty for common bile duct calculi associated with a periampullary diverticulum with no operative or post-operative mortality and minimal morbidity. Follow-up ranging from 20 to 60 months has shown remission of pain in all but one patient, who has had a normal endoscopic cholangiogram and no further episodes of jaundice or cholangitis. Extended transduodenal sphincteroplasty is a safe and effective alternative to choledochoduodenostomy for the surgical management of choledocholithiasis associated with a periampullary diverticulum.

Entities:  

Mesh:

Year:  1992        PMID: 1630978      PMCID: PMC2399419          DOI: 10.1136/pgmj.68.799.346

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  16 in total

1.  Endoscopic sphincterotomy in 1000 consecutive patients.

Authors:  D Vaira; L D'Anna; C Ainley; J Dowsett; S Williams; J Baillie; S Cairns; J Croker; P Salmon; P Cotton
Journal:  Lancet       Date:  1989-08-19       Impact factor: 79.321

2.  Extended sphincteroplasty for juxtapapillary duodenal diverticulum.

Authors:  H H Kaminsky; W R Thompson; B Davis
Journal:  Surg Gynecol Obstet       Date:  1986-03

3.  Is duodenal diverticulum a risk factor for sphincterotomy?

Authors:  D Vaira; J F Dowsett; A R Hatfield; S R Cairns; A A Polydorou; P B Cotton; P R Salmon; R C Russell
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

4.  Endoscopic sphincterotomy for bile duct stones in patients with intact gallbladders.

Authors:  D T Hansell; M A Millar; W R Murray; G R Gray; G Gillespie
Journal:  Br J Surg       Date:  1989-08       Impact factor: 6.939

5.  Transduodenal sphincteroplasty (not sphincterotomy) for biliary and pancreatic disease. Indications, contraindications, and results.

Authors:  S A Jones; R A Steedman; T B Keller; L L Smith
Journal:  Am J Surg       Date:  1969-08       Impact factor: 2.565

6.  Choledochoduodenostomy, transduodenal sphincteroplasty and sphincterotomy for calculi of the common bile duct.

Authors:  A R Baker; J P Neoptolemos; T Leese; D P Fossard
Journal:  Surg Gynecol Obstet       Date:  1987-03

7.  Endoscopic sphincterotomy for common bile duct calculi in patients with gall bladder in situ considered unfit for surgery.

Authors:  B R Davidson; J P Neoptolemos; D L Carr-Locke
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

8.  Recurrent biliary calculi: duodenal diverticula as a predisposing factor.

Authors:  T Løtveit; M Osnes; S Larsen
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

9.  Endoscopic manometry of the sphincter of Oddi in patients with and without juxtapapillary duodenal diverticula.

Authors:  G Viceconte; G W Viceconte; G Bogliolo
Journal:  Scand J Gastroenterol       Date:  1984-05       Impact factor: 2.423

10.  Endoscopic management of common duct stones without cholecystectomy.

Authors:  D F Martin; D E Tweedle
Journal:  Br J Surg       Date:  1987-03       Impact factor: 6.939

View more
  2 in total

Review 1.  Surgical management of pancreaticobiliary disease associated with juxtapapillary duodenal diverticula: case series and review of the literature.

Authors:  Chad M Teven; Eric Grossman; Kevin K Roggin; Jeffrey B Matthews
Journal:  J Gastrointest Surg       Date:  2012-03-06       Impact factor: 3.452

Review 2.  Recurrent ascending cholangitis with acute pancreatitis and pancreatic atrophy caused by a juxtapapillary duodenal diverticulum: A case report and literature review.

Authors:  Nasser A N Alzerwi
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.